Literature DB >> 21400503

MEG3 imprinted gene contribution in tumorigenesis.

Leonidas Benetatos1, George Vartholomatos, Eleftheria Hatzimichael.   

Abstract

Maternally expressed gene 3 (MEG3) is a maternally expressed imprinted gene representing a large noncoding RNA in which microRNAs (miRNAs) and small nucleolar RNAs are also hosted. It is capable of interacting with cyclic AMP, p53, murine double minute 2 (MDM2) and growth differentiation factor 15 (GDF15) playing a role in cell proliferation control. MEG3 expression is under epigenetic control, and aberrant CpG methylation has been observed in several types of cancer. Moreover, gene copy number loss has been reported as additional mechanism associated with tumorigenesis. MEG3 deletion seems to upregulate the paternally expressed genes and on the other hand downregulate the expression of downstream maternally expressed genes and tumor suppressor miRNAs, although there are conflicting data on the topic. MEG3 could represent a tumor suppressor gene located in chromosome 14q32 and its association with tumorigenesis is growing every day.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400503     DOI: 10.1002/ijc.26052

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  126 in total

1.  LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.

Authors:  C Zhou; C Huang; J Wang; H Huang; J Li; Q Xie; Y Liu; J Zhu; Y Li; D Zhang; Q Zhu; C Huang
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 2.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

3.  Uncovering the role of genomic "dark matter" in human disease.

Authors:  Lance Martin; Howard Y Chang
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

4.  Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.

Authors:  Zhijie Zhu; Ling Song; Jun He; Yanan Sun; Xiaomei Liu; Xiaoyan Zou
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 5.  Competing endogenous RNA networks and gastric cancer.

Authors:  Lei-Lei Guo; Chun-Hua Song; Peng Wang; Li-Ping Dai; Jian-Ying Zhang; Kai-Juan Wang
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

6.  Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.

Authors:  Lei Nie; Hsing-Ju Wu; Jung-Mao Hsu; Shih-Shin Chang; Adam M Labaff; Chia-Wei Li; Yan Wang; Jennifer L Hsu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2012-04-08       Impact factor: 4.060

7.  Neighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example.

Authors:  Katherine E King; Jennifer B Kane; Peter Scarbrough; Cathrine Hoyo; Susan K Murphy
Journal:  Biodemography Soc Biol       Date:  2016

Review 8.  Long noncoding RNAs: a new regulatory code in osteoarthritis.

Authors:  Xiao Cen; Xin-Qi Huang; Wen-Tian Sun; Qing Liu; Jun Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 9.  Long Noncoding RNAs in Host-Pathogen Interactions.

Authors:  Federica Agliano; Vijay A Rathinam; Andrei E Medvedev; Sivapriya Kailasan Vanaja; Anthony T Vella
Journal:  Trends Immunol       Date:  2019-04-30       Impact factor: 16.687

Review 10.  DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2014-08-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.